BSEBoard Meeting3d ago · 10 Aug 2026, 10:58 am
Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Pursuance to Regulation ....
Wardwizard Healthcare Ltd · 512063
✦ AI SummaryResults
Wardwizard Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the Un-audited Standalone Financial Results of the Company for the First quarter ended 30th June, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment7/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Wardwizard Healthcare Ltd - 512063 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirement) Regulations 2015.
Attachments (1)
📄pdf
Download →
64f833af-42a1-40e7-ac3b-cff8a154aef2.pdf
View document text
Date: August 10, 2026 Ref: WHL/BSE/BM-INTIMATION-2/2026-27
BSE Limited
Kind Attn.: Corporate Relations Department
Corporate Relations Department
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai-400 001
Ref: - Wardwizard Healthcare Limited (Formerly known as Ayoki Mercantile Limited) (BSE Script
code: 512063)
Sub: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligation and Disclosure
Requirement) Regulations 2015.
Dear Sir/Madam,
Pursuance to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations
2015, as amended from time to time, we here inform you that a meeting of the Board of Directors of
Wardwizard Healthcare Limited (Formerly known as Ayoki Mercantile Limited) (the Company) is
scheduled to be held on Thursday, August 13, 2026 inter-alia, to consider/approve the following
matters:
(i) Approval of Un-audited Standalone Financial Results of the Company for the First quarter
ended 30th June, 2026 for the financial year 2026-27.
(ii) Any other business as the Board deemed fit to discuss, with the permission of the chair and
majority of directors present in the meeting.
Further, we had, vide our letter no. WHL/BSE/TW-Q1/JUNE/2026-27 dated 23th June, 2026, informed
the Exchange about the Closure of Trading Window for all the designated persons defined in the Code
inter alia for the purpose of taking on record the Unaudited Financial Results, in terms of the provisions
of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by SEBI (Prohibition of Insider
Trading) (Amendment) Regulations, 2018 (“SEBI PIT Regulations”) read with Company’s Code of
Conduct – Prohibition of Insider Trading for prevention of Insider Trading adopted by the Company
has already been closed, for dealing in the Company’s Securities from Wednesday, 01st July 2026, till
the completion of 48 hours after the declaration/publication of Unaudited Financial Results of the
Company for the First quarter ended 30th June, 2026 , which will now be till Saturday, 15th August,
2026 and shall open for trading on and from Monday, the 17th August, 2026 (16th August being
Sunday)
Kindly take note of the same.
Thanking you,
For WARDWIZARD HEALTHCARE LIMITED
(Formerly known as Ayoki Merchantile Limited)
RAJBALA KIRORIWAL
COMPANY SECRETARY AND COMPLIANCE OFFICER